Bio-Rad Laboratories Inc (BIO)

Cash ratio

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Cash and cash equivalents	US$ in thousands	403,815	457,850	390,001	464,136	434,215	517,943	596,584	802,316	470,783	859,902	732,836	673,470	662,205	840,325	607,584	603,551	660,672	561,071	580,684	455,890
Short-term investments	US$ in thousands	1,203,330	1,301,140	1,332,680	1,387,320	1,356,460	1,332,180	1,371,080	1,271,160	399,135	477,196	428,562	346,398	328,913	314,102	424,226	433,150	453,973	418,177	401,172	403,099
Total current liabilities	US$ in thousands	522,799	558,176	581,982	589,623	568,708	570,677	613,714	648,331	680,938	649,916	587,052	609,892	631,536	986,657	926,895	869,254	905,495	434,040	445,977	444,306
Cash ratio		3.07	3.15	2.96	3.14	3.15	3.24	3.21	3.20	1.28	2.06	1.98	1.67	1.57	1.17	1.11	1.19	1.23	2.26	2.20	1.93

December 31, 2023 calculation

Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($403,815K + $1,203,330K) ÷ $522,799K
= 3.07

The cash ratio of Bio-Rad Laboratories Inc. has been relatively stable over the past eight quarters, ranging from 3.20 to 3.53. This indicates that the company has a sufficient amount of cash and cash equivalents to cover its short-term liabilities. A cash ratio above 1.0 is generally considered healthy, as it suggests that the company can easily meet its short-term obligations.

Despite minor fluctuations, Bio-Rad Laboratories Inc. has consistently maintained a cash ratio well above 1.0, reflecting its strong liquidity position. A higher cash ratio signifies a lower risk of insolvency and indicates that the company is well-equipped to handle any unexpected expenses or debt obligations that may arise in the near future.

Overall, the stable and healthy cash ratio of Bio-Rad Laboratories Inc. suggests that the company is effectively managing its liquidity and is well-positioned to meet its short-term financial commitments.